Metropolitan Life Insurance Company (MetLife)’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-10,763
| Closed | -$838K | – | 2387 |
|
|
2021
Q4 | $838K | Sell |
10,763
-81
| -0.7% | -$7.15K | 0.01% | 1096 |
|
|
2021
Q3 | $1.04M | Sell |
10,844
-359
| -3% | -$37.9K | 0.02% | 919 |
|
|
2021
Q2 | $1.39M | Buy |
11,203
+1,419
| +15% | +$169K | 0.02% | 759 |
|
|
2021
Q1 | $1.29M | Sell |
9,784
-408
| -4% | -$55.8K | 0.02% | 776 |
|
|
2020
Q4 | $1.35M | Sell |
10,192
-203
| -2% | -$24.5K | 0.02% | 685 |
|
|
2020
Q3 | $1.06M | Sell |
10,395
-265
| -2% | -$22.9K | 0.02% | 713 |
|
|
2020
Q2 | $927K | Buy |
10,660
+852
| +9% | +$68.1K | 0.02% | 778 |
|
|
2020
Q1 | $569K | Sell |
9,808
-309
| -3% | -$25.1K | 0.01% | 978 |
|
|
2019
Q4 | $936K | Buy |
10,117
+701
| +7% | +$61.6K | 0.01% | 929 |
|
|
2019
Q3 | $851K | Buy |
9,416
+595
| +7% | +$67.8K | 0.01% | 951 |
|
|
2019
Q2 | $1.04M | Sell |
8,821
-204
| -2% | -$20.6K | 0.02% | 870 |
|
|
2019
Q1 | $782K | Sell |
9,025
-189
| -2% | -$16.1K | 0.01% | 1022 |
|
|
2018
Q4 | $581K | Sell |
9,214
-29
| -0.3% | -$1.99K | 0.01% | 1099 |
|
|
2018
Q3 | $729K | Sell |
9,243
-184
| -2% | -$12K | 0.01% | 1103 |
|
|
2018
Q2 | $564K | Sell |
9,427
-27,700
| -75% | -$1.49M | 0.01% | 1233 |
|
|
2018
Q1 | $1.5M | Buy |
37,127
+440
| +1% | +$21.5K | 0.02% | 703 |
|
|
2017
Q4 | $1.93M | Sell |
36,687
-41,490
| -53% | -$2.22M | 0.03% | 570 |
|
|
2017
Q3 | $3.68M | Buy |
78,177
+4,641
| +6% | +$187K | 0.02% | 735 |
|
|
2017
Q2 | $2.6M | Buy |
73,536
+743
| +1% | +$22.9K | 0.02% | 864 |
|
|
2017
Q1 | $1.72M | Sell |
72,793
-1,324
| -2% | -$26.2K | 0.01% | 1003 |
|
|
2016
Q4 | $990K | Hold |
74,117
| – | – | 0.01% | 1299 |
|
|
2016
Q3 | $1.38M | Buy |
74,117
+5,782
| +8% | +$102K | 0.01% | 1112 |
|
|
2016
Q2 | $837K | Sell |
68,335
-10,838
| -14% | -$81.6K | 0.01% | 1359 |
|
|
2016
Q1 | $534K | Buy |
79,173
+13,892
| +21% | +$88.9K | ﹤0.01% | 1547 |
|
|
2015
Q4 | $603K | Hold |
65,281
| – | – | ﹤0.01% | 1506 |
|
|
2015
Q3 | $1.17M | Buy |
65,281
+505
| +0.8% | +$11.6K | 0.01% | 1115 |
|
|
2015
Q2 | $1.93M | Sell |
64,776
-2,993
| -4% | -$75.2K | 0.01% | 981 |
|
|
2015
Q1 | $1.49M | Buy |
67,769
+2,862
| +4% | +$72.6K | 0.01% | 1002 |
|
|
2014
Q4 | $1.78M | Buy |
64,907
+2,153
| +3% | +$52.4K | 0.01% | 1016 |
|
|
2014
Q3 | $1.22M | Sell |
62,754
-4,940
| -7% | -$90.6K | 0.01% | 1168 |
|
|
2014
Q2 | $1.15M | Buy |
67,694
+11,947
| +21% | +$164K | 0.01% | 1264 |
|
|
2014
Q1 | $790K | Sell |
55,747
-3,067
| -5% | -$41.4K | 0.01% | 1512 |
|
|
2013
Q4 | $688K | Hold |
58,814
| – | – | ﹤0.01% | 1587 |
|
|
2013
Q3 | $695K | Buy |
58,814
+7,174
| +14% | +$92.1K | 0.01% | 1531 |
|
|
2013
Q2 | $718K | Buy |
+51,640
| New | +$561K | 0.01% | 1454 |
|
Other funds holding EXAS
AIM
NAMA
Metropolitan Life Insurance Company (MetLife)'s EXAS Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Exact Sciences (EXAS) in Q1 2022, closing a stake of 10,763 shares — an estimated $838K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in EXAS in Q2 2013 and held it in 35 quarters. The position peaked at $3.68M in Q3 2017. 559 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Exact Sciences position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 10,763 Exact Sciences shares in Q1 2022, an estimated $838K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Exact Sciences in Q2 2013 and held it in 35 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Exact Sciences position peaked at $3.68M in Q3 2017.
- 559 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.